[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "My vitamin D results", "description": "Vitamin D results\n\nhttps://www.vitamindtest.org.uk\n\nhttps://www.yourpersonalisedvitamins.co.uk\n\nYPV result, 22 ng/ml\n\nNHS result, 84.4 nmol/L = 33.76 ng/ml\n\nTotal vitamin D levels above 220 nmol/L are considered \u2018High\u2019 and increase the risk of vitamin D toxicity\n\n220 nmol/L = 88 ng/ml\n\nUnited States\n\nFDA, Friday, Johnson & Johnson\u2019s coronavirus vaccine\n\nUS, 72 % effective in preventing moderate to severe covid-19 in the United States\n\nSouth Africa, 64%\n\nLatin America, 61%\n\nUS, CDC data\n\nCases, + 464,435 (7 days) = 28,138,938\n\nDeaths, 503,587\n\nhttps://covid.cdc.gov/covid-data-tracker/#cases_totalcases\n\nhttps://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases\n\nUS, VOC status\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html\n\nPast 7 days\n\nhttps://www.washingtonpost.com/graphics/2020/national/coronavirus-us-cases-deaths/?itid=sf_coronavirus\n\nNew daily reported cases, down 6.5%\n\nNew daily reported deaths, up 4.9%\n\nCoViD related hospitalizations, down 12.9%\n\n52,669 (10,846, 3,567)\n\nTest positivity rate, 4.7%\n\nVaccine doses since 14th December, 66,464,000\n\nTwo doses, 20,607,000 (6.31%)\n \nhttps://covidtracking.com/data\n\nUK\n\nThreat level goes down, 5 down to 4\n\nLevel 5, NHS and other health services being overwhelmed within 21 days\n\nLevel 4, NHS, under significant pressure with a high number of patients in hospital\n\nTransmission rates, hospital pressures and deaths are still very high\n\nONS, w/e 19th February\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19roundup/2020-03-26\n\nEngland, Prevalence\n\nOne in 145\n\nEquating to 373,700 people, (0.69%)\n\nWales\n\nOne in 204, 0.48%)\n\nNorthern Ireland\n\nOne in 195, (0.52%)\n\nScotland\n\nOne in 225, (0.45%)\n\nEngland\n\nDeaths, + 5,691 + 6,113\n\n= 122,070 and 135,613\n\nHRH\n\nthink about other people\" and get vaccinated when offered\n\nNadhim Zahawi, vaccine-hesitant, 11-15%\n\nProfessor Calum Semple, (Scientific Advisory Group for Emergencies)\n\nhttps://www.bbc.co.uk/news/live/uk-56207602\n\nPrimary school children are the lowest risk both to themselves and to society\n\nChildren are half to a third as likely to acquire the virus\n\nWhen it comes to transmitting they are probably half as likely to transmit it as adults\n\nThat risk actually gets smaller as you go into younger age groups\n\nI am not a great fan of young children wearing face masks\n\nIf I had to invest in a single activity to improve the environment both for the children and the adults, I'd be looking at improving the ventilation, \n\nunsealing windows that have been painted shut and kept shut for energy-saving reasons\n\nThat would be a much more effective way to reduce transmission in schools\n\nGP LD register\n\nJoint Committee on Vaccination and Immunisation (JCVI)\n\n150,000 to be vaccinated\n\nSevere disabilities\n\nPHE\n\nDeath rate x 6\n\nX 30 in 18-34 age group\n\nMore prone to obesity and diabetes\n\nGlobal cases\n\nhttps://www.bloomberg.com/graphics/2020-coronavirus-cases-world-map/\n\nVaccine tracker\n\nhttps://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/\n\nFrance\n\nMr Macron would accept AZ vaccine", "link": "https://www.youtube.com/watch?v=CmXgau7WFmo", "date_published": "2021-02-26 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Vaccines, excellent real world data", "description": "Pfizer-BioNTech vaccine provides high levels of protection from the first dose\n\nhttps://www.gov.uk/government/news/first-real-world-uk-data-shows-pfizer-biontech-vaccine-provides-high-levels-of-protection-from-the-first-dose\n\nhttps://papers.ssrn.com/sol3/papers.cfm?abstract_id=3790399\n\nBNT162b2 mRNA\n\nVaccine effectiveness in healthcare worker\n\nProspective cohort study of staff undergoing regular asymptomatic testing.\n\nThe SIREN study\n\nN = 29,378\n\n2 weekly intervals\n\nRecords symptoms, PCR and antibody test results\n\nTherefore symptomatic and asymptomatic infections\n\nHazard ratios to compare time\n\nInfection in unvaccinated and vaccinated groups\n\n\nFindings, 5th February 2021\n\nPeople who were antibody negative on recruitment\n\nA single dose of BNT162b2 vaccine, effectiveness of 72%\n\n21 days after first dose\n\nRising to 86% seven days after two doses\n\nConclusion\n\nVaccine effectively prevents both symptomatic and asymptomatic infection in working age adults\n\nCohort was vaccinated when the dominant variant in circulation was B1.1.7\n\nConsistent data\n\nIsrael, Norwich Medical School \n\nPfizer COVID-19 BNT162b2 vaccine, after a single dose, \u2018real-world\u2019\n\nAt day 21\n\nVaccine effectiveness, 91%\n\nAfter day 21\n\nRemained at 90%\n\nExpected to last form 9 weeks to 6 months\n\nVaccine effectiveness seems to be better at reducing severe disease that at reducing mild disease\n\nPublic health Scotland\n\nFourth week after first dose, reduced risk of hospitalisation\n\nPfizer, down 84% (n = 650,000) \n\nOxford-AstraZeneca, down 94% (n = 490,000)\n\nCombined reduction in over 80s\n\nVaccination associated with 81% reduction in hospitalisation risk in the fourth week", "link": "https://www.youtube.com/watch?v=e-ApgJMVkM0", "date_published": "2021-02-25 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]